Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131360) titled 'A Comparative Study of 7.0T versus 3.0T MRI for Brain Metastasis Detection: Image Quality and Diagnostic Performance with Low-Dose Gadolinium Contrast Agent and Different Sequences' on Sept. 1.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Qilu Hospital of Shandong University
Condition:
Brain metastases
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-01
Target Sample Size: Observation group:112;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341178
Disclaimer: Curated by HT Syndicat...